Feasibility of Sentinel Lymph Node Biopsy in Rectal Cancer
Status:
Terminated
Trial end date:
2020-12-01
Target enrollment:
Participant gender:
Summary
This study will assess whether the Sienna+/Sentimag system, which involves a magnetic tracer,
is effective in identifying the sentinel lymph node in rectal cancer and whether it is then
feasible to remove this lymph node during surgery to locally excise early rectal cancer.
Phase:
N/A
Details
Lead Sponsor:
Oxford University Hospitals NHS Trust
Collaborators:
Endomagnetics Limited Endomagnetics Ltd. University of Leeds